Oral administration of semicarbazide limits weight gain together with inhibition of fat deposition and of primary amine oxidase activity in adipose tissue

Journal of Obesity

Volumn 2011, Issue , 2011, Pages

  Mercader, Josep ^a,b   Iffiú Soltész, Zsuzsa ^a,b   Bour, Sandy ^b   Carpéné, Christian ^a,b  

^a INSERM   (France)

^b CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79957560463     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2011/475786     Document Type: Article

References (49)

1. Yu P. H., Wang M., Fan H., Deng Y., Gubisne-Haberle D., Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice. American Journal of Physiology 2004 286 4 E634 E641 2-s2.0-1642313880 10.1152/ajpendo.00272.2003 (Pubitemid 38374962)
2. Mercier N., El Hadri K., Osborne-Pellegrin M., Nehme J., Perret C., Labat C., Regnault V., Lamazière J. M. D., Challande P., Lacolley P., Fève B., Modifications of arterial phenotype in response to amine oxidase inhibition by semicarbazide. Hypertension 2007 50 1 234 241 2-s2.0-34250841846 10.1161/HYPERTENSIONAHA.107.089292 (Pubitemid 46986046)
3. Mercier N., Kakou A., Challande P., Lacolley P., Osborne-Pellegrin M., Comparison of the effects of semicarbazide and β -aminopropionitrile on the arterial extracellular matrix in the Brown Norway rat. Toxicology and Applied Pharmacology 2009 239 3 258 267 2-s2.0-69249202267 10.1016/j.taap.2009.06.005
4. Yu P. H., Zuo D. M., Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia 1997 40 11 1243 1250 2-s2.0-0030785422 10.1007/s001250050816 (Pubitemid 27469662)
5. Nilsson B. O., Biological effects of aminoguanidine: an update. Inflammation Research 1999 48 10 509 515 2-s2.0-0032697984 10.1007/s000110050495 (Pubitemid 29495631)
6. Prévot D., Soltesz Z., Abello V., Wanecq E., Valet P., Unzeta M., Carpéné C., Prolonged treatment with aminoguanidine strongly inhibits adipocyte semicarbazide-sensitive amine oxidase and slightly reduces fat deposition in obese Zucker rats. Pharmacological Research 2007 56 1 70 79 2-s2.0-34347268113 10.1016/j.phrs.2007.04.002 (Pubitemid 46994754)
7. Carpéné C., Iffiú-Soltesz Z., Bour S., Prévot D., Valet P., Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats. Pharmacological Research 2007 56 6 522 530 2-s2.0-36348999936 10.1016/j.phrs.2007.09.016 (Pubitemid 350148166)
8. Carpéné C., Abello V., Iffiú-Soltész Z., Mercier N., Fève B., Valet P., Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors. Pharmacological Research 2008 57 6 426 434 2-s2.0-47249143213 10.1016/j.phrs.2008.04.005
9. O'Sullivan J., Unzeta M., Healy J., O'Sullivan M. I., Davey G., Tipton K. F., Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do. NeuroToxicology 2004 25 1-2 303 315 2-s2.0-0347415714 10.1016/S0161-813X(03) 00117-7 (Pubitemid 38044191)
10. Jalkanen S., Karikoski M., Mercier N., Koskinen K., Henttinen T., Elima K., Salmivirta K., Salmi M., The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood 2007 110 6 1864 1870 2-s2.0-34548825637 10.1182/blood-2007-01-069674 (Pubitemid 47443898)
11. El Hadri K., Moldes M., Mercier N., Andreani M., Pairault J., Feve B., Semicarbazide-sensitive amine oxidase in vascular smooth muscle cells: differentiation-dependent expression and role in glucose uptake. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 1 89 94 2-s2.0-0036143578 10.1161/hq0102.101550 (Pubitemid 34076237)
12. Conforti L., Raimondi L., Lyles G. A., Metabolism of methylamine by semicarbazide-sensitive amine oxidase in white and brown adipose tissue of the rat. Biochemical Pharmacology 1993 46 4 603 607 2-s2.0-0027186406 10.1016/0006-2952(93)90544-7 (Pubitemid 23262952)
13. Ochiai Y., Itoh K., Sakurai E., Tanaka Y., Molecular cloning and characterization of rat semicarbazide-sensitive amine oxidase. Biological and Pharmaceutical Bulletin 2005 28 3 413 418 2-s2.0-21144437888 10.1248/bpb.28.413 (Pubitemid 40879960)
14. Valente T., Solé M., Unzeta M., SSAO/VAP-1 protein expression during mouse embryonic development. Developmental Dynamics 2008 237 9 2585 2593 2-s2.0-51549121993 10.1002/dvdy.21682
15. Morin N., Lizcano J. M., Fontana E., Marti L., Smih F., Rouet P., Prévot D., Zorzano A., Unzeta M., Carpéné C., Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes. Journal of Pharmacology and Experimental Therapeutics 2001 297 2 563 572 2-s2.0-0035028044 (Pubitemid 32377986)
16. Iffiú-Soltész Z., Wanecq E., Lomba A., Portillo M. P., Pellati F., Szöko É., Bour S., Woodley J., Milagro F. I., Alfredo Martinez J., Valet P., Carpéné C., Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice. Pharmacological Research 2010 61 4 355 363 2-s2.0-77949272097 10.1016/j.phrs.2009.12.014
17. Fontana E., Boucher J., Marti L., Lizcano J. M., Testar X., Zorzano A., Carpene C., Amine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cells. Biochemical Journal 2001 356 3 769 777 2-s2.0-0035875559 10.1042/0264-6021:3560769 (Pubitemid 32588448)
18. Mercier N., Moldes M., El Hadri K., Fève B., Semicarbazide- sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells. Biochemical Journal 2001 358 2 335 342 2-s2.0-0035447729 10.1042/0264-6021: 3580335 (Pubitemid 32826349)
19. Carpéné C., Daviaud D., Boucher J., Bour S., Visentin V., Grès S., Duffaut C., Fontana E., Testar X., Saulnier-Blache J. S., Valet P., Short- and long-term insulin-like effects of monoamine oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes. Metabolism 2006 55 10 1397 1405 2-s2.0-33748441342 10.1016/j.metabol.2006.06.011 (Pubitemid 44353559)
20. Chiche F., Le Guillou M., Chétrite G., Lasnier F., Dugail I., Carpéné C., Moldes M., Fève B., Antidepressant phenelzine alters differentiation of cultured human and mouse preadipocytes. Molecular Pharmacology 2009 75 5 1052 1061 2-s2.0-66049138191 10.1124/mol.108.052563
21. Maranghi F., Tassinari R., Lagatta V., Moracci G., Macrì C., Eusepi A., Di Virgilio A., Scattoni M. L., Calamandrei G., Effects of the food contaminant semicarbazide following oral administration in juvenile Sprague-Dawley rats. Food and Chemical Toxicology 2009 47 2 472 479 2-s2.0-58149500687 10.1016/j.fct.2008.12.003
22. Takahashi M., Yoshida M., Inoue K., Morikawa T., Nishikawa A., A ninety-day toxicity study of semicarbazide hydrochloride in Wistar Hannover GALAS rats. Food and Chemical Toxicology 2009 47 10 2490 2498 2-s2.0-69549109851 10.1016/j.fct.2009.07.008
23. Vlastos D., Moshou H., Epeoglou K., Evaluation of genotoxic effects of semicarbazide on cultured human lymphocytes and rat bone marrow. Food and Chemical Toxicology 2010 48 1 209 214 2-s2.0-72249106204 10.1016/j.fct.2009.10. 002
24. Visentin V., Bour S., Boucher J., Prévot D., Valet P., Ordener C., Parini A., Carpéné C., Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide. European Journal of Pharmacology 2005 522 1-3 139 146 2-s2.0-26844508332 10.1016/j.ejphar.2005.08.051 (Pubitemid 41456660)
25. Bour S., Daviaud D., Gres S., Lefort C., Prévot D., Zorzano A., Wabitsch M., Saulnier-Blache J. S., Valet P., Carpéné C., Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes. Biochimie 2007 89 8 916 925 2-s2.0-34447280866 10.1016/j.biochi.2007.02.013 (Pubitemid 47044864)
26. Boucher J., Castan-Laurell I., Daviaud D., Guigné C., Buléon M., Carpéné C., Saulnier-Blache J. S., Valet P., Adipokine expression profile in adipocytes of different mouse models of obesity. Hormone and Metabolic Research 2005 37 12 761 767 2-s2.0-29744445534 10.1055/s-2005-921098 (Pubitemid 43028079)
27. Lay S. L., Krief S., Farnier C., Lefrère I., Liepvre X. L., Bazin R., Ferré P., Dugail I., Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. Journal of Biological Chemistry 2001 276 20 16904 16910 2-s2.0-0035907394 10.1074/jbc.M010955200
28. Iffiú-Soltész Z., Prévot D., Carpéné C., Influence of prolonged fasting on monoamine oxidase and semicarbazide- sensitive amine oxidase activities in rat white adipose tissue. Journal of Physiology and Biochemistry 2009 65 1 11 24 2-s2.0-67249148046 10.1007/BF03165965
29. Abramsson-Zetterberg L., Svensson K., Semicarbazide is not genotoxic in the flow cytometry-based micronucleus assay in vivo. Toxicology Letters 2005 155 2 211 217 2-s2.0-10444256210 10.1016/j.toxlet.2004.09.019 (Pubitemid 39643206)
30. Pfundstein B., Tricker A. R., Theobald E., Spiegelhalder B., Preussmann R., Mean daily intake of primary and secondary amines from foods and beverages in West Germany in 1989-1990. Food and Chemical Toxicology 1991 29 11 733 739 2-s2.0-0026317393 10.1016/0278-6915(91)90181-6
31. McCabe-Sellers B. J., Staggs C. G., Bogle M. L., Tyramine in foods and monoamine oxidase inhibitor drugs: a crossroad where medicine, nutrition, pharmacy, and food industry converge. Journal of Food Composition and Analysis 2006 19 S58 S65 2-s2.0-33646508750 10.1016/j.jfca.2005.12.008
32. Gabastou J. M., Nugon-Baudon L., Robert Y., Manuel C., Vaissade P., Bourgeon E., Sibeud M., Szylit O., Bourlioux P., Digestives amines of bacterial origin and behaviour. A case report. Pathologie Biologie 1996 44 4 275 281 2-s2.0-0029898342 (Pubitemid 26171616)
33. Visentin V., Marq P., Bour S., Subra C., Prévot D., Morin N., Valet P., Monje M. C., Nepveu F., Carpéné C., Effect of prolonged treatment with tyramine on glucose tolerance in streptozotocin-induced diabetic rats. Journal of Physiology and Biochemistry 2003 59 3 225 232 2-s2.0-10744226923 (Pubitemid 38208135)
34. Neurath G. B., Duenger M., Pein F. G., Primary and secondary amines in the human environment. Food and Cosmetics Toxicology 1977 15 4 275 282 (Pubitemid 8166642)
35. Noda K., Nakao S., Zandi S., Engelstädter V., Mashima Y., Hafezi-Moghadam A., Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes. Experimental Eye Research 2009 89 5 774 781 2-s2.0-70349456530 10.1016/j.exer.2009.07.010
36. Dray C., Knauf C., Daviaud D., Waget A., Boucher J., Buléon M., Cani P. D., Attané C., Guigné C., Carpéné C., Burcelin R., Castan-Laurell I., Valet P., Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metabolism 2008 8 5 437 445 2-s2.0-54849424539 10.1016/j.cmet.2008.10.003
37. Langin D., Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacological Research 2006 53 6 482 491 2-s2.0-33646778517 10.1016/j.phrs.2006.03.009 (Pubitemid 43767551)
38. Hoenicke K., Gatermann R., Hartig L., Mandix M., Otte S., Formation of semicarbazide (SEM) in food by hypochlorite treatment: is SEM a specific marker for nitrofurazone abuse? Food Additives and Contaminants 2004 21 6 526 537 2-s2.0-3042815785 10.1080/02652030410001712484 (Pubitemid 38885964)
39. Bendall J. G., Semicarbazide is non-specific as a marker metabolite to reveal nitrofurazone abuse as it can form under Hofmann conditions. Food Additives and Contaminants Part A 2009 26 1 47 56 2-s2.0-59049090757 10.1080/02652030802190276
40. Maranghi F., Tassinari R., Marcoccia D., Altieri I., Catone T., De Angelis G., Testai E., Mastrangelo S., Evandri M. G., Bolle P., Lorenzetti S., The food contaminant semicarbazide acts as an endocrine disrupter: evidence from an integrated in vivo/in vitro approach. Chemico-Biological Interactions 2010 183 1 40 48 2-s2.0-71349084218 10.1016/j.cbi.2009.09.016
41. Matsushima S., Hori S., Matsuda M., Conversion of 4-aminobutyraldehyde to γ -aminobutyric acid in striatum treated with semicarbazide and kainic acid. Neurochemical Research 1986 11 9 1313 1319 2-s2.0-0022998257 (Pubitemid 17172473)
42. Borelli K. G., Ferreira-Netto C., Brandão M. L., Distribution of Fos immunoreactivity in the rat brain after freezing or escape elicited by inhibition of glutamic acid decarboxylase or antagonism of GABA-A receptors in the inferior colliculus. Behavioural Brain Research 2006 170 1 84 93 2-s2.0-33646164655 10.1016/j.bbr.2006.02.015
43. Zanoveli J. M., Brandão M. L., The dorsal periaqueductal and basolateral amygdala are necessary for the expression of conditioned place avoidance induced by semicarbazide stimulation of the dorsal periaqueductal region. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008 32 7 1715 1721 2-s2.0-51349123398 10.1016/j.pnpbp.2008.07.008
44. DeMarco A., Dalal R. M., Kahanda M., Mullapudi U., Pai J., Hammel C., Liebling C. N. B., Patel V., Brodie J. D., Schiffer W. K., Dewey S. L., Aquilina S. D., Subchronic racemic gamma vinyl-GABA produces weight loss in Sprague Dawley and Zucker fatty rats. Synapse 2008 62 11 870 872 2-s2.0-52249089584 10.1002/syn.20555
45. Coscina D. V., Nobrega J. N., Anorectic potency of inhibiting GABA transaminase in brain: studies of hypothalamic, dietary and genetic obesities. International Journal of Obesity 1984 8 1 191 200 2-s2.0-0021611916 (Pubitemid 15019741)
46. Fisler J. S., Shimizu H., Bray G. A., Brain 3-hydroxybutyrate, glutamate, and GABA in a rat model of dietary obesity. Physiology and Behavior 1989 45 3 571 577 2-s2.0-0024505530 (Pubitemid 19124337)
47. Jain E., Kumar Y., Stables J., Sinha R., Menthone semicarbazides and thiosemicarbazides as anticonvulsant agents. Medicinal Chemistry 2010 6 1 44 50 2-s2.0-77950869424 10.2174/157340610791208727
48. Bandhuvula P., Fyrst H., Saba J. D., A rapid fluorescence assay for sphingosine-1-phosphate lyase enzyme activity. Journal of Lipid Research 2007 48 12 2769 2778 2-s2.0-37249006747 10.1194/jlr.D700010-JLR200 (Pubitemid 350272861)
49. Murakami A., Takasugi H., Ohnuma S., Koide Y., Sakurai A., Takeda S., Hasegawa T., Sasamori J., Konno T., Hayashi K., Watanabe Y., Mori K., Sato Y., Takahashi A., Mochizuki N., Takakura N., Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P receptor: investigation based on a new S1P receptor antagonist. Molecular Pharmacology 2010 77 4 704 713 2-s2.0-77950231687 10.1124/mol.109.061481